Welcome to Trendlines
We invest in, incubate, and support early-stage, high-promise medical and agricultural technology companies in Israel, a global leader in start-up ingenuity. Read More >
Subscribe to Our Newsletter
Stay in Touch
Creating & Developing Companies To Improve the Human Condition
… Collaboration for Trendlines Labs … Steve Rhodes in the media … 7th Annual Showcase videos and photos … OB Smart wins at TechCode Beijing … Hargol FoodTech wins at Innovation for Humanity …
Congratulations! Trendlines Labs will collaborate with Singapore General Hospital and SIIRD on a clinical trial of its stress urinary incontinence device.
Chairman and CEO Steve Rhodes was featured in The Marker’s popular “Internal Dialogue” column. … Another interview with Steve appeared in etnet.
Chairman and CEO Todd Dollinger has been named to the board of the AO Development Incubator, part of the AO Foundation.
Our Annual General Meeting was held 26 April at the Suntec International Convention & Exhibition Centre, Singapore.
Philip Securities Research reported on Trendlines in “A portfolio of disruptive technologies in untapped markets.”
Congratulations to the Maryland/Israel Development Center (MIDC) on its 25th anniversary and to Executive Director Barry Bogage as the Hanan Y. Sibel Maryland/Israel Business Leadership honoree.
Our 7th Annual Company Showcase
On 29 March, hundreds of attendees from around the world learned lessons from the “Waze journey,” gained insights into Trendlines’ deal flow process, heard presentations from nine of our medical and agtech portfolio companies, and networked and mingled on a bright spring day.
Voices from the Showcase: Why is the Showcase so important?
7 REASONS TO MEET US AT BIOMED … BOOTH #59
1. Meet our entrepreneurs and see our products
2. Meet the Trendlines Medical team
3. Meet the Trendlines Labs team
4. Meet the Trendlines Marcom team
5. Meet the Trendlines Operations team
6. Meet us at our 2nd Biomed Happy Hour, 23-24 May, 14:00
7. Meet the winners of the Trendlines Medtech Open (to be announced 25 May)
23-25 May | David InterContinental, Tel Aviv | Booth #59
Congratulations! ElastiMed has been awarded €50,000 as part of Horizon 2020 SME Instrument. Horizon 2020 is the “EU framework programme for research and innovation.” The money will “finance feasibility studies for new products that can disrupt the market.”
Fidmi Medical was featured in The Times of Israel, “Israeli startup creates user-friendly, cost-saving feeding tube.”
See the interview with Tandem Technologies CEO Noam Hassidov on ILTV.
At conferences … VP Business Development Barak Singer attended the 24th MedTech Investing Europe Conference in Lausanne, Switzerland, 5-6 April. … Zeev Implants CEO Pinchas Kfir attended the 37th International Dental Show in Cologne, Germany, 21-25 March. … Seger Surgical Solutions CEO Kobby Greenberg attended the SAGES Conference in Houston, Texas, 22-24 March.
Welcome! Limaca Medical is our newest portfolio company. The Company is involved in endoscopic ultrasound fine needle biopsy. Assaf Klein is Limaca’s CEO.
In other news from Hargol … Dror Tamir presented to Rothschild Innovation Tour participants at the Forbes Under 30 Summit hosted by Startup Nation Central. … The Company will present at the Pearse Lyons Accelerator Dublin Showcase on 27 April. … Hargol was featured in the Russian media.
Congratulations! Trendlines Labs will collaborate with Singapore General Hospital and SIIRD on a clinical trial of the Trendlines Labs’ stress urinary incontinence device.
Director of Business Development Nir Goldenberg is a panelist on “Digital Health: Guiding Startups Through Unique Challenges” at the Charité BIH Entrepreneurship Summit 2017 in Berlin, 8-9 May. See the conference program (PDF).
The Business Times featured Trendlines Medical Singapore in “Trendlines to deepen presence in Singapore.”
Channel News Asia featured Trendlines Medical Singapore and an interview with CEO Eric Loh in “Government of Singapore sets aside SGD$20m for first-time entrepreneurs.”
|If you are a passionate entrepreneur with an exciting new idea or product in medical or agriculture/food technologies, we want to hear from you.|